Saegis Pharmaceuticals

About:

Saegis Pharmaceuticals is focused on the development of medicines that address behavioral disorders.

Website: http://www.saegispharma.com/

Top Investors: Sofinnova Partners, Polaris Partners, Versant Ventures, Sofinnova Investments, Technology Partners

Description:

Saegis Pharmaceuticals is focused on the development of medicines that address behavioral disorders. The company has a pipeline of treatments for central nervous system diseases involving cognitive dysfunction, including Alzheimer’s disease, mild cognitive impairment, attention deficit hyperactivity disorder, and cognitive impairment associated with schizophrenia. It develops CNS therapeutics for patients facing memory loss and cognition deficits associated with aging, psychiatric disorders, and brain trauma. Saegis Pharmaceuticals was founded in 1999 and is based in Half Moon Bay, California.

Total Funding Amount:

$44M

Headquarters Location:

Half Moon Bay, California, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)saegispharma.com

Founders:

Rodney Pearlman

Number of Employees:

1-10

Last Funding Date:

2003-11-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai